Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 401–500 of 860
Luo, W., Guo, Z., Wu, M., Hao, C., Hu, X., Zhou, Z., Zhou, Z., Yao, X., Zhang, L., & Liu, J. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120110 · Cited by 41
Duszka, K., & Wahli, W. (2020) · Nutrients · doi:10.3390/nu12113476 · Cited by 40
Foreman, J. E., Sorg, J. M., McGinnis, K. S., Rigas, B., Williams, J. L., Clapper, M. L., Gonzalez, F. J., & Peters, J. M. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20546 · Cited by 41
Orphan nuclear receptors: therapeutic opportunities in skeletal muscle
Smith, A. G., & Muscat, G. E. O. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00476.2005 · Cited by 36
Dimopoulos, N., Watson, M., Green, C., & Hundal, H. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.072 · Cited by 36
“that receptor activation promotes expression of genes important for fatty acid uptake, lipid catabolism and energy expenditure [11,14].”
BackgroundMethodInfluentialPeroxisome proliferator-activated receptor delta and cardiovascular disease
Ehrenborg, E., & Skogsberg, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.027 · Cited by 37
Skeletal muscle respiratory capacity is enhanced in rats consuming an obesogenic Western diet
Stephenson, E. J., CAMERA, D. M., Jenkins, T. A., Kosari, S., Lee, J. S., Hawley, J. A., & Stepto, N. K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2011 · Cited by 42
BCL-6: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells
Kharroubi, I., Lee, C., Hekerman, P., Darville, M. I., Evans, R. M., Eizirik, D. L., & Cnop, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0366-5 · Cited by 41
Iida, S., Kohro, T., Kodama, T., Nagata, S., & Fukunaga, R. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904515 · Cited by 41
Self-citationGW0742, A HIGH-AFFINITY PPAR -β/δ AGONIST, INHIBITS ACUTE LUNG INJURY IN MICE
Paola, R. D., Crisafulli, C., Mazzon, E., Esposito, E., Paterniti, I., Galuppo, M., Genovese, T., Thiemermann, C., & Cuzzocrea, S. (2010) · Shock · doi:10.1097/shk.0b013e3181b8f2fb · Cited by 36
Regulation of fatty acid transport
Kalant, D., & Cianflone, K. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00011 · Cited by 47
Norepinephrine and rosiglitazone synergistically induceElovl3expression in brown adipocytes
Jörgensen, J. A., Zadravec, D., & Jacobsson, A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00213.2007 · Cited by 38
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Ortiz‐López, N., Fuenzalida, C., Dufeu, M. S., Pinto-León, A., Escobar, A. F., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954869 · Cited by 40
Kim, J. H., Kim, J., & Park, Y. (2012) · Lipids · doi:10.1007/s11745-012-3698-6 · Cited by 41
Yu, J., Ahn, S.-Y., Kim, H. J., Lee, M. Y., Ahn, S., Kim, J., Jin, S. H., Lee, E., Kim, G., Cheong, J. H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00805 · Cited by 37
Feng, Z., Xiang, J., Liu, H., Li, J., Xu, X., Sun, G., Zheng, R., Zhang, S., Liu, J., Yang, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02002 · Cited by 37
Chen, W., Wang, L., Liu, H., Long, L., & Li, S. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00268.x · Cited by 37
Ravaux, L., Denoyelle, C., Monne, C., Limon, I., Raymondjean, M., & Hadri, K. E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00623-07 · Cited by 37
Nuclear receptors and metabolism: from feast to famine
Hong, S.-H., Ahmadian, M., Yu, R. T., Atkins, A. R., Downes, M., & Evans, R. M. (2014) · Diabetologia · doi:10.1007/s00125-014-3209-9 · Cited by 34
Quintela, A. M., Jiménez, R., Piqueras, L., Gómez‐Guzmán, M., Haro, J., Zarzuelo-Romero, M. J., Cogolludo, A. L., Sanz, M., Toral, M., Romero, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12646 · Cited by 40
Murakami, K., Sasaki, Y., Asahiyama, M., Yano, W., Takizawa, T., Kamiya, W., Matsumura, Y., Anai, M., Osawa, T., Fruchart, J., et al. (2022) · Cells · doi:10.3390/cells11040720 · Cited by 36
Self-citationSassa, M., Inoue, I., Shinoda, Y., Takahashi, S., Seo, M., Komoda, T., Awata, T., & Katayama, S. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.2790 · Cited by 34
Michiels, J., Perrin, C., Cardot‐Leccia, N., Massi, D., Grimaldi, P. A., & Wagner, N. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0776-6 · Cited by 37
Wu, C., Gilroy, R. K., Taylor, R. M., Olyaee, M. S., Abdulkarim, B., Forster, J., O’Neil, M. F., Damjanov, I., & Wan, Y. Y. (2010) · Hepatology · doi:10.1002/hep.24645 · Cited by 34
Borland, M. G., Khozoie, C., Albrecht, P. P., Zhu, B., Lee, C., Lahoti, T. S., Gonzalez, F. J., & Peters, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.020 · Cited by 36
Hu, C., Jia, W., Fang, Q., Zhang, R., Wang, C., Lu, J., & Xiang, K. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02001.x · Cited by 38
Gielen, M., Westerterp‐Plantenga, M. S., Bouwman, F. G., Joosen, A. M. C. P., VLIETINCK, R. F., Derom, C. A., Zeegers, M. P., Mariman, E. C. M., & Westerterp, K. R. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0415-5 · Cited by 35
Coll, T., Barroso, E., Álvarez-Guardia, D., Serrano, L., Salvadó, L., Merlos, M., Palomer, X., & Vázquez‐Carrera, M. (2010) · PPAR Research · doi:10.1155/2010/368467 · Cited by 38
Zamora, M., Pardo, R., & Villena, J. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.032 · Cited by 34
Feng, Y. Z., Nikolić, N., Bakke, S. S., Boekschoten, M. V., Kersten, S., Kase, E. T., Rustan, A. C., & Thoresen, G. H. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.829105 · Cited by 39
Peroxisome Proliferator‐Activated Receptors and Progression of Colorectal Cancer
Wang, D., & DuBois, R. N. (2008) · PPAR Research · doi:10.1155/2008/931074 · Cited by 31
PPARδ activator GW-501516 has no acute effect on glucose transport in skeletal muscle
Terada, S., Wicke, S., Holloszy, J. O., & Han, D.-H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2005 · Cited by 32
Muscle development and obesity: Is there a relationship?
Maltin, C. A. (2008) · Organogenesis · doi:10.4161/org.4.3.6312 · Cited by 48
Ikeda, Y., Iguchi, H., Nakata, M., Ioka, R. X., Tanaka, T., Iwasaki, S., Magoori, K., Takayasu, S., Yamamoto, T. T., Kodama, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.005 · Cited by 33
Self-citationMcCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.034 · Cited by 36
GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes
Cariou, B., & Staels, B. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954034 · Cited by 36
PPARβ/δ activation of CD300a controls intestinal immunity
Tanaka, T., Tahara‐Hanaoka, S., Nabekura, T., Ikeda, K., Jiang, S. S., Tsutsumi, S., Inagaki, T., Magoori, K., Higurashi, T., Takahashi, H., et al. (2014) · Scientific Reports · doi:10.1038/srep05412 · Cited by 31
Self-citationChorner, Z., Barbeau, P., Castellani, L. N., Wright, D. C., Chabowski, A., & Holloway, G. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00346.2016 · Cited by 36
Protective Effects of Polyphenols Present in Mediterranean Diet on Endothelial Dysfunction
Stromsnes, K., Mas‐Bargues, C., Gambini, J., & Gimeno-Mallench, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2097096 · Cited by 35
PPAR Agonists and Cardiovascular Disease in Diabetes
Calkin, A. C., & Thomas, M. C. (2008) · PPAR Research · doi:10.1155/2008/245410 · Cited by 32
Benton, C. R., Koonen, D. P. Y., Calles-Escandón, J., Tandon, N. N., Glatz, J. F. C., Luiken, J. J. F. P., Heikkila, J. J., & Bonen, A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.106013 · Cited by 34
Zhang, M., Barroso, E., Peña, L., Rada, P., Valverde, Á. M., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117303 · Cited by 34
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress
Hayes, C. M., Gallucci, G. M., Boyer, J. L., Assis, D. N., & Ghonem, N. S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000612 · Cited by 35
Faulkner, A., Lynam, E. G., Purcell, R. H., Jones, C. A., Lopez, C. A., Mary Board, Wagner, K., Wagner, N., Carr, C. A., & Wheeler-Jones, C. P. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-63900-0 · Cited by 32
Fasting Drives Nrf2-Related Antioxidant Response in Skeletal Muscle
Lettieri‐Barbato, D., Minopoli, G., Caggiano, R., Izzo, R., Santillo, M., Aquilano, K., & Faraonio, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207780 · Cited by 33
Løvås, K., Røst, T. H., Skorve, J., Ulvik, R. J., Gudbrandsen, O. A., Bohov, P., Wensaas, A. J., Rustan, A. C., Berge, R. K., & Husebye, E. S. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00958.x · Cited by 31
Exercise‐Induced cytokines, diet, and inflammation and their role in adipose tissue metabolism
Al‐Ibraheem, A. M. T., Hameed, A. A. Z., Marsool, M. D. M., Jain, H., Prajjwal, P., Khazmi, I., Nazzal, R., Al-Najati, H. M. H., Al‐Zuhairi, B. H. Y. K., Razzaq, M., et al. (2024) · Health Science Reports · doi:10.1002/hsr2.70034 · Cited by 36
Vella, C. A., Nelson, O. L., Jansen, H. T., Robbins, C. T., Jensen, A. E., Constantinescu, S., Abbott, M. J., & Turcotte, L. P. (2019) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2019.110591 · Cited by 38
Diet-Induced Obesity Prevents Interstitial Dispersion of Insulin in Skeletal Muscle
Kolka, C. M., Harrison, L. N., Lottati, M., Chiu, J. D., Kirkman, E. L., & Bergman, R. N. (2009) · Diabetes · doi:10.2337/db09-0839 · Cited by 29
Bortolotto, J. W., Margis, R., Ferreira, Â. C. B., Padoin, A. V., Mottin, C. C., & Guaragna, R. M. V. D. C. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9172-5 · Cited by 33
McNamara, L. B., Giblin, L. M., Markham, T., Stickland, N. C., Berry, D. P., O'Reilly, J. J., Lynch, P. B., Kerry, J. P., & Lawlor, P. G. (2011) · animal · doi:10.1017/s1751731111000176 · Cited by 29
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists. Part 2
Epple, R., Azimioara, M. D., Russo, R., Xie, Y., Wang, X., Cow, C., Wityak, J., Karanewsky, D. S., Bursulaya, B. D., Kreusch, A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.052 · Cited by 31
Zeng, L., Geng, Y., Tretiakova, M., Yu, X., Siciński, P., & Kroll, T. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0855 · Cited by 31
Efdé, M., Houtman, P. M., Spoorenberg, J. P. L., & Jansen, T. (2005) · PubMed · Cited by 31
Pérez‐Schindler, J., & Philp, A. (2015) · Clinical Science · doi:10.1042/cs20150246 · Cited by 29
MEHP interferes with mitochondrial functions and homeostasis in skeletal muscle cells
Chen, Y.-H., Wu, Y.-J., Chen, W.-C., Lee, T., Tsou, T., Chang, H.-C., Lo, S.-W., & Chen, S. L. (2020) · Bioscience Reports · doi:10.1042/bsr20194404 · Cited by 28
Kasuga, J.-I., Ishikawa, M., Yonehara, M., Makishima, M., Hashimoto, Y., & Miyachi, H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.041 · Cited by 29
Baldan, A., Relat, J., Marrero, P. F., & Haro, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh806 · Cited by 33
Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410
Norisada, N., Masuzaki, H., Fujimoto, M., Inoue, G., Hosoda, K., Hayashi, T., Watanabe, M., Muraoka, S., Yoneda, F., & Nakao, K. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.020 · Cited by 28
Self-citationFedoseeva, L. A., Klimov, L. O., Ershov, N., Alexandrovich, Y., Efimov, V. M., Markel, А. L., & Redina, O. E. (2016) · BMC Genomics · doi:10.1186/s12864-016-3354-2 · Cited by 29
Jin, X., Xue, B., Ahmed, R. Z., Ding, G., & Li, Z. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.02.083 · Cited by 27
Fuentes, E., & Palomo, I. F. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/861786 · Cited by 32
Ngala, R. A., Stocker, C. J., Roy, A. G., Hislop, D. C., Wargent, E. T., Bell, R., Hassall, D. G., Harling, J. D., Billin, A. N., Willson, T. M., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01371.x · Cited by 26
Constantin‐Teodosiu, D., Baker, D. J., Constantin, D., & Greenhaff, P. L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164210 · Cited by 27
Shen, L., Zhang, Y., Wang, A., Sieber-McMaster, E. S., Chen, X., Pelton, P. D., Xu, J. Z., Yang, M., Zhu, P., Zhou, L., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.12.005 · Cited by 27
Kim, M. S., Kung, S., Grewal, T., & Roufogalis, B. D. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112799095310 · Cited by 31
Howard, E. E., & Margolis, L. M. (2020) · Nutrients · doi:10.3390/nu12092496 · Cited by 26
PPARαIs Required for PPARδAction in Regulation of Body Weight and Hepatic Steatosis in Mice
Garbacz, W. G., Huang, J. T.-J., Higgins, L. G., Wahli, W., & Palmer, C. N. A. (2015) · PPAR Research · doi:10.1155/2015/927057 · Cited by 28
Improving metabolism by increasing energy expenditure
Auwerx, J. H. (2006) · Nature Medicine · doi:10.1038/nm0106-44 · Cited by 28
Self-citationYoussef, J., & Badr, M. Z. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-155-4_1 · Cited by 28
Design and synthesis of a novel class of dual PPARγ/δ agonists
Gonzalez, I. C., Lamar, J., Iradier, F., Xu, Y., Winneroski, L. L., York, J. S., Yumibe, N. P., Zink, R. W., Montrose‐Rafizadeh, C., Etgen, G. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.029 · Cited by 26
Ali, F., Ismail, A., Esa, N. M., & Chong, P. P. (2014) · Genomics · doi:10.1016/j.ygeno.2014.11.002 · Cited by 25
Mariani, S., Rocco, G. D., Toietta, G., Russo, M. A., Petrangeli, E., & Salvatori, L. (2016) · Endocrine · doi:10.1007/s12020-016-1170-8 · Cited by 25
Kashiwada, M., Nakaishi, S., Usuda, A., Miyahara, Y., Katsumoto, K., Katsura, K., Terakado, I., Jindo, M., Nakajima, S., Ogawa, S., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01537-7 · Cited by 29
Ye, J., Tid-Ang, J. D., Turner, N. A., Zeng, X., Li, H., Cooney, G. J., Wulff, E. M., Sauerberg, P., & Kraegen, E. W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01240.x · Cited by 30
Wang, D., & DuBois, R. N. (2010) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.08.014 · Cited by 24
Keil, S., Matter, H., Schönafinger, K., Glien, M., Mathieu, M., Marquette, J.-P., Michot, N., Haag‐Diergarten, S., Urmann, M., & Wendler, W. (2011) · ChemMedChem · doi:10.1002/cmdc.201100047 · Cited by 29
Jucker, B. M., Yang, D., Casey, W., Olzinski, A. R., Williams, C., Lenhard, S. C., Legos, J. J., Hawk, C. T., Sarkar, S. K., & Newsholme, S. J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2007 · Cited by 35
Polysaccharide-Enriched Fraction from Amillariella Mellea Fruiting Body Improves Insulin Resistance
Yang, S., Meng, Y., Yan, J., Wang, N., Xue, Z., Zhang, H., & Fan, Y. (2018) · Molecules · doi:10.3390/molecules24010046 · Cited by 26
Sáez, M. E., Grilo, A., Morón, F. J., Manzano, L., Martinez-Larrad, M. T., González‐Pérez, A., Serrano-Hernando, F. J., Ruiz, A., Ramírez‐Lorca, R., & Serrano‐Ríos, M. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-23 · Cited by 29
Hu, S., Yao, J., Howe, A. A., Menke, B. M., Sivitz, W. I., Spector, A. A., & Norris, A. W. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1253 · Cited by 27
Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist
Zhao, S., Kanno, Y., Li, W., 若旅穂奈美, Sasaki, T., Koike, K., Nemoto, K., & Li, H. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00909 · Cited by 29
Effective treatments for insulin resistance: trim the fat and douse the fire
Evans, J. L., YOUNGREN, J. F., & Goldfine, I. D. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.005 · Cited by 32
Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.08.001 · Cited by 26
Burch, L. R., Donnelly, L. A., Doney, A. S. F., Brady, J. D., Tommasi, A. M., Whitley, A. L., Goddard, C. A., Morris, A. D., Hansen, M. K., & Palmer, C. N. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1201 · Cited by 26
Orabi, D., Berger, N. A., & Brown, J. M. (2021) · Cancers · doi:10.3390/cancers13143473 · Cited by 28
Binding and activity of bisphenol analogues to human peroxisome proliferator-activated receptor β/δ
Li, C.-H., Zhang, D., Jiang, L., Qi, Y., & Guo, L. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112849 · Cited by 26
Kemmerer, M., Finkernagel, F., Cavalcante, M. F., Abdalla, D. S. P., Müller, R., Brüne, B., & Namgaladze, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130893 · Cited by 27
Aoki, H., Hanayama, M., Mori, K., & Sato, R. (2018) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1480348 · Cited by 25
Application of DNA Microarrays in the Study of Human Obesity and Type 2 Diabetes
Sun, G. (2007) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2006.0003 · Cited by 29
Sasaki, H., Ogawa, K., Shimizu, M., Mori, C., Takatsuka, H., Okazaki, F., Kawai, M., Taniguchi, I., & Mochizuki, S. (2007) · International Heart Journal · doi:10.1536/ihj.48.623 · Cited by 24
Jové, M., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.02.002 · Cited by 32
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists: Part 1
Epple, R., Russo, R., Azimioara, M. D., Cow, C., Xie, Y., Wang, X., Wityak, J., Karanewsky, D. S., Gerken, A., Iskandar, M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.055 · Cited by 25
Watanabe, N., Komiya, Y., Sato, Y., Watanabe, Y., Suzuki, T., & Arihara, K. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.099 · Cited by 26
Self-citationFeng, H., Yousuf, S., Liu, T., Zhang, X., Huang, W., Ai, L., Xie, L., & Miao, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-21045-2 · Cited by 28
May, L. T., Bartolo, B. A. D., Harrison, D. G., Guzik, T. J., Drummond, G. R., Figtree, G. A., Ritchie, R. H., Rye, K., & de Haan, J. B. (2022) · Clinical Science · doi:10.1042/cs20210862 · Cited by 24
Sharma, A. K., Raikwar, S. K., Kurmi, M. K., & Srinivasan, B. P. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0154-4 · Cited by 23
Kasuga, J.-I., Ishida, S., Yamasaki, D., Makishima, M., Doi, T., Hashimoto, Y., & Miyachi, H. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.021 · Cited by 23
Self-citationMechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene
d’Uscio, L. V., He, T., Santhanam, A. V. R., Tai, L.-J., Evans, R. M., & Katušić, Z. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00761.2013 · Cited by 25
PPARδ agonists and metabolic diseases
Kang, K., Hatano, B., & Lee, C. (2007) · Current Atherosclerosis Reports · doi:10.1007/bf02693931 · Cited by 27
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.